Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3269273 | HPB | 2013 | 6 Pages |
Abstract
BL remains frequent after liver resection. It has a dramatic impact on patient survival and care costs. Its incidence could be reduced by avoiding the preâoperative use of bevacizumab, avoiding selective clamping and performing a blue dye test in all resections.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Antoine Guillaud, Claire Pery, Boris Campillo, Anne Lourdais, Sulpice Laurent, Karim Boudjema,